Oxford Nanopore Technologies Plc (ONT) – Strategy, SWOT and Corporate Finance Report

Oxford Nanopore Technologies Plc (ONT) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Oxford Nanopore Technologies Plc (Oxford Nanopore), formerly Oxford NanoLabs Ltd develops disruptive, electronic, and single-molecule sensing system. The company’s products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, the UK.

Scope

• Detailed information on Oxford Nanopore Technologies Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Oxford Nanopore Technologies Plc in the form of a SWOT analysis

• An in-depth view of the business model of Oxford Nanopore Technologies Plc including a breakdown and examination of key business segments

• News about Oxford Nanopore Technologies Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Oxford Nanopore Technologies Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Oxford Nanopore Technologies Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Oxford Nanopore Technologies Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Illumina Inc

Source BioScience (Healthcare) Ltd

Pacific Biosciences of California Inc

Roche Diagnostics International Ltd

NanoString Technologies Inc

Quest Diagnostics Inc

Exact Sciences Corp

Adaptive Biotechnologies Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Oxford Nanopore Technologies Plc - Key Facts

Oxford Nanopore Technologies Plc - Key Employees

Oxford Nanopore Technologies Plc - Key Employee Biographies

Oxford Nanopore Technologies Plc - Major Products and Services

Oxford Nanopore Technologies Plc - History

Oxford Nanopore Technologies Plc - Company Statement

Oxford Nanopore Technologies Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Oxford Nanopore Technologies Plc - Business Description

Business Segment: Covid-19 Testing

Overview

Performance

Business Segment: Life Science Research Tools (LSRT)

Overview

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific and Japan

Performance

Geographical Segment: China

Performance

Geographical Segment: Emerging Markets

Performance

Geographical Segment: Europe and United Kingdom

Performance

Geographical Segment: United Arab Emirates

Performance

R&D Overview

Oxford Nanopore Technologies Plc - Corporate Strategy

Oxford Nanopore Technologies Plc - SWOT Analysis

SWOT Analysis - Overview

Oxford Nanopore Technologies Plc - Strengths

Oxford Nanopore Technologies Plc - Weaknesses

Oxford Nanopore Technologies Plc - Opportunities

Oxford Nanopore Technologies Plc - Threats

Oxford Nanopore Technologies Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Oxford Nanopore Technologies Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 09, 2023: Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing

Apr 14, 2023: Oxford Nanopore and BioMerieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics

Mar 31, 2023: Announces new human health and disease study led by the UK National Institute for Health and Care Research (NIHR) BioResource

Mar 21, 2023: Oxford Nanopore Technologies Announces Final results for the year ended 31 December 2022

Mar 21, 2023: Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market

Mar 20, 2023: Oxford Nanopore and 4bases announce collaboration to combine nanopore sequencing devices and 4bases kits to support rapid, high-accuracy analyses in human and cancer genetics, with a first target of same-day BRCA1 and BRCA2 analysis

Mar 16, 2023: Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer

Feb 27, 2023: Oxford Nanopore Technologies : Changes to Director roles and responsibilities

Feb 09, 2023: SeqOne genomics and the French Thrombotic MicroAngiopathies National Reference Center (CNR-MAT) pioneer the use of oxford nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times

Jan 17, 2023: Oxford Nanopore Technologies : Trading update

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Oxford Nanopore Technologies Plc, Key Facts

Oxford Nanopore Technologies Plc, Key Employees

Oxford Nanopore Technologies Plc, Key Employee Biographies

Oxford Nanopore Technologies Plc, Major Products and Services

Oxford Nanopore Technologies Plc, History

Oxford Nanopore Technologies Plc, Other Locations

Oxford Nanopore Technologies Plc, Key Competitors

Oxford Nanopore Technologies Plc, Ratios based on current share price

Oxford Nanopore Technologies Plc, Annual Ratios

Oxford Nanopore Technologies Plc, Annual Ratios (Cont…1)

Oxford Nanopore Technologies Plc, Annual Ratios (Cont…2)

Oxford Nanopore Technologies Plc, Interim Ratios

Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2017 to YTD 2023

Oxford Nanopore Technologies Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Oxford Nanopore Technologies Plc, Performance Chart (2018 – 2022)

Oxford Nanopore Technologies Plc, Ratio Charts

Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023

Oxford Nanopore Technologies Plc, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports